anmelden
OMX Nordic 40
2.710,14
PKT
+1,71
PKT
+0,06
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu OMX Nordic 40-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 01.06.26 | AstraZeneca Overweight | Barclays Capital | |
| 01.06.26 | Hennes Mauritz (H M, H&M) Sector Perform | RBC Capital Markets | |
| 01.06.26 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 29.05.26 | Novo Nordisk Hold | Jefferies & Company Inc. | |
| 29.05.26 | Hennes Mauritz (H M, H&M) Hold | Jefferies & Company Inc. | |
| 28.05.26 | AstraZeneca Sell | Deutsche Bank AG | |
| 28.05.26 | Novo Nordisk Hold | Deutsche Bank AG | |
| 28.05.26 | Hennes Mauritz (H M, H&M) Neutral | UBS AG | |
| 27.05.26 | Volvo (B) Buy | Goldman Sachs Group Inc. | |
| 21.05.26 | Hennes Mauritz (H M, H&M) Underweight | Barclays Capital | |
| 21.05.26 | AstraZeneca Sell | Deutsche Bank AG | |
| 20.05.26 | Nokia Overweight | JP Morgan Chase & Co. | |
| 20.05.26 | ABB (Asea Brown Boveri) Equal Weight | Barclays Capital | |
| 20.05.26 | Hennes Mauritz (H M, H&M) Hold | Deutsche Bank AG | |
| 20.05.26 | Novo Nordisk Hold | Deutsche Bank AG | |
| 20.05.26 | Volvo (B) Hold | Deutsche Bank AG | |
| 20.05.26 | Hennes Mauritz (H M, H&M) Sell | Goldman Sachs Group Inc. | |
| 20.05.26 | Hennes Mauritz (H M, H&M) Underweight | JP Morgan Chase & Co. | |
| 19.05.26 | Novo Nordisk Equal Weight | Barclays Capital | |
| 19.05.26 | ABB (Asea Brown Boveri) Equal Weight | Barclays Capital | |
| 18.05.26 | Hennes Mauritz (H M, H&M) Sector Perform | RBC Capital Markets | |
| 15.05.26 | Nokia Buy | Deutsche Bank AG | |
| 14.05.26 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 13.05.26 | AstraZeneca Buy | Jefferies & Company Inc. | |
| 13.05.26 | Novo Nordisk Hold | Jefferies & Company Inc. | |
| 12.05.26 | Novo Nordisk Underperform | Bernstein Research | |
| 08.05.26 | Novo Nordisk Hold | Deutsche Bank AG | |
| 08.05.26 | Volvo (B) Buy | Jefferies & Company Inc. | |
| 08.05.26 | Novo Nordisk Neutral | JP Morgan Chase & Co. | |
| 08.05.26 | ABB (Asea Brown Boveri) Neutral | UBS AG | |
| 08.05.26 | Novo Nordisk Neutral | UBS AG | |
| 08.05.26 | Novo Nordisk Equal Weight | Barclays Capital | |
| 08.05.26 | ABB (Asea Brown Boveri) Equal Weight | Barclays Capital | |
| 07.05.26 | ABB (Asea Brown Boveri) Hold | Jefferies & Company Inc. | |
| 07.05.26 | Novo Nordisk Halten | DZ BANK | |
| 07.05.26 | Novo Nordisk Hold | Deutsche Bank AG | |
| 07.05.26 | Novo Nordisk Equal Weight | Barclays Capital | |
| 06.05.26 | ABB (Asea Brown Boveri) Sector Perform | RBC Capital Markets | |
| 06.05.26 | Novo Nordisk Underperform | Bernstein Research | |
| 06.05.26 | Novo Nordisk Neutral | JP Morgan Chase & Co. |
